• Trypanosoma cruzi (T. cruzi) Antibody, IgM
  • Polycythemia vera
  • Methamphetamine, Urine
  • Platelet Antibodies, Serum
  • Blood Culture (Bloodstream Infection) Pathogen and Resistance Gene Panel, Molecular
  • HER2/neu (ERBB2) Gene Amplification, FISH, Breast Cancer
  • CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • Salla Disease Mutation Analysis
  • Familial Mediterranean Fever (MEFV) Gene Mutation Analysis
  • Bruton Tyrosine Kinase (BTK) Protein Expression by Flow Cytometry
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS
Medical Test

Overview
Access to Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS is restricted.